Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 342 results.
User Information
Export Records
  1. 1.   PLS-a-GalCer: a novel targeted glycolipid therapy for solid tumors
  2. Burks, Julian; Tiwary, Shweta; Stevens, David M; Skoczen,Sarah; Kularatne,Ruvanthi Nilanga; Stern,Stephan; Berzofsky, Jay A
  3. Journal for Immunotherapy of Cancer. 2025, Mar 22; 13(3):
  1. 2.   Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity
  2. Hangasky, John A; Fernández, Rocío Del Valle; Stellas,Dimitris; Hails, Guillermo; Karaliota,Sevasti; Ashley, Gary W; Felber,Barbara; Pavlakis,George; Santi, Daniel V
  3. Frontiers in Immunology. 2024, Nov 4; 15: 1458145.
  1. 3.   Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
  2. Davar, Diwakar; Morrison, Robert M; Dzutsev, Amiran K; Karunamurthy, Arivarasan; Chauvin, Joe-Marc; Amatore, Florent; Deutsch, Julie S; Das Neves, Rodrigo X; Rodrigues,Richard; McCulloch, John A; Wang, Hong; Hartman, Douglas J; Badger, Jonathan H; Fernandes, Miriam R; Bai, Yulong; Sun, Jie; Cole, Alicia M; Aggarwal, Poonam; Fang, Jennifer R; Deitrick, Christopher; Bao, Riyue; Duvvuri, Umamaheswar; Sridharan, Shaum S; Kim, Seungwon W; A Choudry, Haroon; Holtzman, Matthew P; Pingpank, James F; O'Toole, James Patrick; DeBlasio, Richelle; Jin, Yang; Ding, Quanquan; Gao, Wentao; Groetsch, Christopher; Pagliano, Ornella; Rose, Amy; Urban, Corey; Singh, Jagjit; Divarkar, Prajan; Mauro, David; Bobilev, Dmitri; Wooldridge, James; Krieg, Arthur M; Fury, Matthew G; Whiteaker, Jeffrey R; Zhao, Lei; Paulovich, Amanda G; Najjar, Yana G; Luke, Jason J; Kirkwood, John M; Taube, Janis M; Park, Hyun Jung; Trinchieri, Giorgio; Zarour, Hassane M
  3. Cancer Cell. 2024, Oct 30;
  1. 4.   Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
  2. Larkin, Riley M; Lopez, Diana C; Robbins, Yvette L; Lassoued, Wiem; Canubas, Kenneth; Warner,Andrew; Karim,Baktiar; Vulikh, Ksenia; Hodge, James W; Floudas, Charalampos S; Gulley, James L; Gallia, Gary L; Allen, Clint T; London, Nyall R
  3. Journal of Translational Medicine. 2024, May 31; 22(1): 524.
  1. 5.   Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor
  2. Wang, Mengjiao; Wan, Quan; Wang, Chenglv; Jing, Qianyu; Nie, Yujie; Zhang, Xiangyan; Chen, Xin; Yang,De; Pan, Runsang; Li, Linzhao; Zhu, Lan; Gui, Huan; Chen, Shuanghui; Deng, Yuezhen; Chen, Tao; Nie, Yingjie
  3. Molecular and Cellular Biochemistry. 2024, Mar 20;
  1. 6.   Phototruncation cell tracking with near-infrared photoimmunotherapy using heptamethine cyanine dye to visualise migratory dynamics of immune cells
  2. Fukushima, Hiroshi; Furusawa, Aki; Takao, Seiichiro; Matikonda, Siddharth S; Kano, Makoto; Okuyama, Shuhei; Yamamoto, Hiroshi; Choyke, Peter L; Schnermann,Martin; Kobayashi, Hisataka
  3. EBioMedicine. 2024, Mar 14; 102: 105050.
  1. 7.   Lineage and ecology define liver tumor evolution in response to treatment
  2. Revsine, Mahler; Wang, Limin; Forgues, Marshonna; Behrens, Shay; Craig, Amanda J; Liu, Meng; Tran,Bao; Kelly,Michael; Budhu, Anuradha; Monge, Cecilia; Xie, Changqing; Hernandez, Jonathan M; Greten, Tim F; Wang, Xin Wei; Ma, Lichun
  3. Cell Reports. Medicine. 2024, Feb 20; 5(2): 101394.
  1. 8.   Extracellular Matrix Scaffold-Assisted Tumor Vaccines Induce Tumor Regression And Long-Term Immune Memory
  2. Pal,Sanjay; Chaudhari, Rohan; Baurceanu,Iris; Hill,Brenna; Nagy,Bethany; Wolf,Matthew
  3. Advanced Materials (Deerfield Beach, Fla.). 2024, Feb 01; e2309843.
  1. 9.   Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin is overcome by targeting a juxtamembrane epitope
  2. Liu, X F; Onda, M; Schlomer,Jerome; Bassel,Laura; Kozlov,Serguei; Tai, C-H; Zhou, Q; Liu, W; Tsao, H-E; Hassan, R; Ho, M; Pastan, I
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Jan 23; 121(4): e2317283121.
  1. 10.   Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common HLA-B and TAP transcriptional silencing across advanced pediatric solid cancers
  2. Lim, Wan Ching; Marques Da Costa, Maria Eugenia; Godefroy, Karine; Jacquet, Eric; Gragert, Loren; Rondof, Windy; Marchais, Antonin; Nhiri, Naima; Dalfovo, Davide; Viard,Mathias; Labaied, Nizar; Khan, Asif M; Dessen, Philippe; Romanel, Alessandro; Pasqualini, Claudia; Schleiermacher, Gudrun; Carrington,Mary; Zitvogel, Laurence; Scoazec, Jean-Yves; Geoerger, Birgit; Salmon, Jerome
  3. Frontiers in Immunology. 2024, Jan 22; 14: 1265469.
  1. 11.   Tumor Suppression by Anti-Fibroblast Activation Protein Near-Infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts
  2. Glabman, Raisa A; Olkowski, Colleen P; Minor, Hannah A; Bassel,Laura; Kedei, Noemi; Choyke, Peter L; Sato, Noriko
  3. Cancers. 2024, Jan 20; 16(2):
  1. 12.   Abrogation of the G2/M checkpoint as a chemo sensitization approach for alkylating agents
  2. Lang, Fengchao; Cornwell, James A; Kaur, Karambir; Elmogazy, Omar; Zhang, Wei; Zhang, Meili; Song, Hua; Sun,David; Wu,Xiaolin; Aladjem, Mirit I; Aregger,Michael; Cappell, Steven D; Yang, Chunzhang
  3. Neuro-Oncology. 2023, Dec 22;
  1. 13.   Recent Advances in the Development of Non-Invasive Imaging Probes for Cancer Immunotherapy
  2. Kazim,Muhammad; Yoo,Euna
  3. Angewandte Chemie (International ed. in English). 2023, Oct 16; e202310694.
  1. 14.   Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor Treatment
  2. Huang,Yue; Nahar, Saifun; Alam, Md Masud; Hu, Shuo; McVicar,Dan; Yang,De
  3. ACS Nano. 2023, Oct 13;
  1. 15.   First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Ra, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
  2. Leidner, Rom; Conlon, Kevin; McNeel, Douglas G; Wang-Gillam, Andrea; Gupta, Sumati; Wesolowski, Robert; Chaudhari, Monica; Hassounah, Nadia; Lee, Jong Bong; Ho Lee, Lang; O'Keeffe, Jessica A; Lewis, Nancy; Pavlakis,George; Thompson, John A
  3. Journal for Immunotherapy of Cancer. 2023, Oct; 11(10):
  1. 16.   Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics
  2. Ade, Catherine M; Sporn, Matthew J; Das,Sudipto; Yu, Zhiya; Hanada, Ken-Ichi; Qi, Yue A; Maity, Tapan; Zhang, Xu; Guha, Udayan; Andresson,Thorkell; Yang, James C
  3. Journal for Immunotherapy of Cancer. 2023, Sep; 11(9):
  1. 17.   Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin
  2. Ruf, Benjamin; Bruhns, Matthias; Babaei, Sepideh; Kedei, Noemi; Ma, Lichun; Revsine, Mahler; Benmebarek, Mohamed-Reda; Ma, Chi; Heinrich, Bernd; Subramanyam, Varun; Qi, Jonathan; Wabitsch, Simon; Green, Benjamin L; Bauer, Kylynda C; Myojin, Yuta; Greten, Layla T; McCallen, Justin D; Huang, Patrick; Trehan, Rajiv; Wang, Xin; Nur, Amran; Murphy Soika, Dana Qiang; Pouzolles, Marie; Evans, Christine N; Chari,Raj; Kleiner, David E; Telford, William; Dadkhah, Kimia; Ruchinskas, Allison; Stovroff, Merrill K; Kang, Jiman; Oza, Kesha; Ruchirawat, Mathuros; Kroemer, Alexander; Wang, Xin Wei; Claassen, Manfred; Korangy, Firouzeh; Greten, Tim F
  3. Cell. 2023, Aug 17; 186(17): 3686-3705.e32.
  1. 18.   Effects of maternal HIV infection on early Kaposi's sarcoma-associated herpesvirus (KSHV) seroconversion in a Kenyan mother-infant cohort
  2. Sabourin, Katherine R; Ogolla, Sidney; Samayoa Reyes, Gabriela; Daud, Ibrahim; Jackson, Conner L; Labo,Nazzarena; Miley,Wendell; Whitby,Denise; Lamb, Molly M; Rochford, Rosemary; Dent, Arlene
  3. The Journal of Infectious Diseases. 2023, Aug 04;
  1. 19.   Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy
  2. Budhu, Anuradha; Pehrsson,Erica; He, Aiwu; Goyal, Lipika; Kelley, Robin Kate; Dang, Hien; Xie, Changqing; Monge, Cecilia; Tandon, Mayank; Ma, Lichun; Revsine, Mahler; Kuhlman, Laura; Zhang, Karen; Baiev, Islam; Lamm, Ryan; Patel, Keyur; Kleiner, David E; Hewitt, Stephen M; Tran,Bao; Shetty,Jyoti; Wu,Xiaolin; Zhao,Yongmei; Shen,Tsai-Wei; Choudhari,Sulbha; Kriga,Yuliya; Ylaya, Kris; Warner,Andrew; Edmondson,Elijah; Forgues, Marshonna; Greten, Tim F; Wang, Xin Wei
  3. Cell Reports. Medicine. 2023, May 16; 4(6): 101052.
  1. 20.   Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population
  2. Stellas, Dimitris; Karaliota,Sevasti; Stravokefalou, Vasiliki; Angel, Matthew; Nagy,Bethany; Goldfarbmuren,Kate; Bergamaschi, Cristina; Felber,Barbara; Pavlakis,George
  3. Cell Reports. 2023, May 12; 42(5): 112501.
  1. 21.   Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies
  2. Nahar,Saifun; Huang,Yue; Nagy,Bethany; Zebala, John A; Maeda, Dean Y; Rudloff, Udo; Oppenheim, Joost J; Yang,De
  3. Cancers. 2023, Apr 19; 15(8):
  1. 22.   Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer
  2. Sievers, Cem; Craveiro, Marco; Friedman, Jay; Robbins, Yvette; Yang, Xinping; Bai, Ke; Nguyen, Andy; Redman, Jason M; Chari,Raj; Soon-Shiong, Patrick; Schlom, Jeffrey; Gulley, James; Allen, Clint T
  3. Cancer Cell. 2023, Apr 12; 41(5): 887-902.e5.
  1. 23.   Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer
  2. Zhu, Lan; Zhang, Xiangyan; Chen, Xin; Yang,De; Nie, Yujie; Pan, Runsang; Li, Linzhao; Wang, Chenglv; Gui, Huan; Chen, Shuanghui; Jing, Qianyu; Wang, Mengjiao; Nie, Yingjie
  3. Biochemical and Biophysical Research Communications. 2023, Feb 16; 653: 106-114.
  1. 24.   Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer
  2. Monge, Cecilia; Xie, Changqing; Myojin, Yuta; Coffman, Kelley; Hrones, Donna Mabry; Wang, Sophie; Hernandez, Jonathan M; Wood, Bradford J; Levy, Elliot B; Juburi, Israa; Hewitt, Stephen M; Kleiner, David E; Steinberg, Seth M; Figg, William D; Redd, Bernadette; Homan,Philip; Cam, Maggie; Ruf, Benjamin; Duffy, Austin G; Greten, Tim F
  3. Journal for Immunotherapy of Cancer. 2023, Feb; 11(2):
  1. 25.   Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
  2. Sun, Ming; Cao, Yingying; Okada, Reona; Reyes-González, Jeyshka M; Stack, Hannah G; Qin, Haiying; Li, Nan; Seibert,Charlie; Kelly, Michael C; Ruppin, Eytan; Ho, Mitchell; Thiele, Carol J; Nguyen, Rosa
  3. Journal for Immunotherapy of Cancer. 2023, Jan; 11(1):
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel